Cite
Defining the critical hurdles in cancer immunotherapy
MLA
Fox, Ba, et al. Defining the Critical Hurdles in Cancer Immunotherapy. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn962296304&authtype=sso&custid=ns315887.
APA
Fox, B., Schendel, D., Butterfield, L., Aamdal, S., Allison, J., Ascierto, P., Atkins, M., Bartunkova, J., Bergmann, L., Berinstein, N., Bonorino, C., Borden, E., Bramson, J., Britten, C., Cao, X., Carson, W., Chang, A., Characiejus, D., Raja Choudhury, A., … Zitvogel, L. (2011). Defining the critical hurdles in cancer immunotherapy.
Chicago
Fox, Ba, Dj Schendel, Lh Butterfield, S Aamdal, Jp Allison, Pa Ascierto, Mb Atkins, et al. 2011. “Defining the Critical Hurdles in Cancer Immunotherapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn962296304&authtype=sso&custid=ns315887.